Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Хроническая сердечная недостаточность: эволюция этиологии, распространенности и смертности за последние 20 лет - Журнал Терапевтический архив №1 Поликлинические проблемы и организация медицинской помощи 2022
Хроническая сердечная недостаточность: эволюция этиологии, распространенности и смертности за последние 20 лет
Бойцов С.А. Хроническая сердечная недостаточность: эволюция этиологии, распространенности и смертности за последние 20 лет. Терапевтический архив. 2022;94(1):5–8.
DOI: 10.26442/00403660.2022.01.201317
DOI: 10.26442/00403660.2022.01.201317
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Статья посвящена анализу изменений роли причинных и коморбидных факторов риска развития двух основных форм сердечной недостаточности – со сниженной и с сохраненной фракцией выброса – в предшествующие примерно 20 лет. В рамках этого же временного интервала рассматривается динамика распространенности и смертности. Отдельное внимание уделено возможному варианту решения проблемы сложности учета случаев диагностики и лечения хронической сердечной недостаточности в амбулаторной и госпитальной практике.
Ключевые слова: хроническая сердечная недостаточность, эволюция, этиология, распространенность, смертность
Keywords: chronic heart failure, evolution, etiology, prevalence, mortality
Ключевые слова: хроническая сердечная недостаточность, эволюция, этиология, распространенность, смертность
________________________________________________
Keywords: chronic heart failure, evolution, etiology, prevalence, mortality
Полный текст
Список литературы
1. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Знакомьтесь: диастолическая сердечная недостаточность. Сердечная недостаточность. 2000;1(2):40-4 [Belenkov IuN, Ageev FT, Mareev VIu. Meet diastolic heart failure. Serdechnaia nedostatochnost'. 2000;1(2):40-4 (in Russian)].
2. Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure. 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. 2020;13(2):e006472. DOI:10.1161/CIRCHEARTFAILURE.119.006472:e006472
3. Maddox T, Januzzi JL, Allen LA, et al. 2021 Upd ate to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Se t Oversight Committee. J Am Coll Cardiol. 2021;77(6):772-810. DOI:10.1016/j.jacc.2020.11.022
4. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;8:7-13 [Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Jjournal of Cardiology. 2016;8:7-13 (in Russian)].
DOI:10.15829/1560-4071-2016-8-7-13
5. Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Infez Med. 2020;28(4):500-6.
6. Buckley BJR, Harrison SL, Fazio-Eynullayeva E, et al. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021;51(11):e13679. DOI:10.1111/eci.13679
7. Lee CCE, Ali K, Connell D, еt al. COVID-19-Associated Cardiovascular Complications. Diseases. 2021;9(3):47. DOI:10.3390/diseases9030047
8. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. MedRxiv. 2021;2021.07.23.21260998 (Preprint). DOI:10.1101/2021.07.23.21260998
9. Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PloS One. 2021;16(7):e0254523. DOI:10.1371/journal.pone.0254523
10. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. DOI:10.1002/ejhf.1858
11. Gerber Y, Weston SA, Redfield MM, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996-1004. DOI:10.1001/jamainternmed.2015.0924
12. Поляков Д.С., Фомин И.В., Беленков Ю.Н., и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14 [Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14 (in Russian)]. DOI:10.18087/cardio.2021.4.n1628
13. Sutcliffe S, Phillips C, Watson D, Davidson C. Trends in heart failure mortality in England and Wales since 1950. Eur J Intern Med. 2007;18(8):576-80.
DOI:10.1016/j.ejim.2007.03.014
14. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14(3):234-9. DOI:10.1093/eurjhf/hfr182
15. Spitaleri G, Lupón J, Domingo M, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep. 2021;11(1):732.
DOI:10.1038/s41598-020-79926-3
16. Buddeke J, Valstar GB, Dis I, et al. Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men. BMC Public Health. 2020;20(1):36. DOI:10.1186/s12889-019-7934-3
17. Available at: https://wonder.cdc.gov/controller/datarequest/D76. Accessed: 16.09.2021.
2. Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure. 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. 2020;13(2):e006472. DOI:10.1161/CIRCHEARTFAILURE.119.006472:e006472
3. Maddox T, Januzzi JL, Allen LA, et al. 2021 Upd ate to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Se t Oversight Committee. J Am Coll Cardiol. 2021;77(6):772-810. DOI:10.1016/j.jacc.2020.11.022
4. [Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Jjournal of Cardiology. 2016;8:7-13 (in Russian).
DOI:10.15829/1560-4071-2016-8-7-13
5. Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Infez Med. 2020;28(4):500-6.
6. Buckley BJR, Harrison SL, Fazio-Eynullayeva E, et al. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021;51(11):e13679. DOI:10.1111/eci.13679
7. Lee CCE, Ali K, Connell D, еt al. COVID-19-Associated Cardiovascular Complications. Diseases. 2021;9(3):47. DOI:10.3390/diseases9030047
8. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. MedRxiv. 2021;2021.07.23.21260998 (Preprint). DOI:10.1101/2021.07.23.21260998
9. Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PloS One. 2021;16(7):e0254523. DOI:10.1371/journal.pone.0254523
10. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. DOI:10.1002/ejhf.1858
11. Gerber Y, Weston SA, Redfield MM, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996-1004. DOI:10.1001/jamainternmed.2015.0924
12. Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14 (in Russian). DOI:10.18087/cardio.2021.4.n1628
13. Sutcliffe S, Phillips C, Watson D, Davidson C. Trends in heart failure mortality in England and Wales since 1950. Eur J Intern Med. 2007;18(8):576-80.
DOI:10.1016/j.ejim.2007.03.014
14. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14(3):234-9. DOI:10.1093/eurjhf/hfr182
15. Spitaleri G, Lupón J, Domingo M, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep. 2021;11(1):732.
DOI:10.1038/s41598-020-79926-3
16. Buddeke J, Valstar GB, Dis I, et al. Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men. BMC Public Health. 2020;20(1):36. DOI:10.1186/s12889-019-7934-3
17. Available at: https://wonder.cdc.gov/controller/datarequest/D76. Accessed: 16.09.2021.
2. Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure. 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. 2020;13(2):e006472. DOI:10.1161/CIRCHEARTFAILURE.119.006472:e006472
3. Maddox T, Januzzi JL, Allen LA, et al. 2021 Upd ate to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Se t Oversight Committee. J Am Coll Cardiol. 2021;77(6):772-810. DOI:10.1016/j.jacc.2020.11.022
4. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;8:7-13 [Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Jjournal of Cardiology. 2016;8:7-13 (in Russian)].
DOI:10.15829/1560-4071-2016-8-7-13
5. Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Infez Med. 2020;28(4):500-6.
6. Buckley BJR, Harrison SL, Fazio-Eynullayeva E, et al. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021;51(11):e13679. DOI:10.1111/eci.13679
7. Lee CCE, Ali K, Connell D, еt al. COVID-19-Associated Cardiovascular Complications. Diseases. 2021;9(3):47. DOI:10.3390/diseases9030047
8. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. MedRxiv. 2021;2021.07.23.21260998 (Preprint). DOI:10.1101/2021.07.23.21260998
9. Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PloS One. 2021;16(7):e0254523. DOI:10.1371/journal.pone.0254523
10. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. DOI:10.1002/ejhf.1858
11. Gerber Y, Weston SA, Redfield MM, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996-1004. DOI:10.1001/jamainternmed.2015.0924
12. Поляков Д.С., Фомин И.В., Беленков Ю.Н., и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14 [Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14 (in Russian)]. DOI:10.18087/cardio.2021.4.n1628
13. Sutcliffe S, Phillips C, Watson D, Davidson C. Trends in heart failure mortality in England and Wales since 1950. Eur J Intern Med. 2007;18(8):576-80.
DOI:10.1016/j.ejim.2007.03.014
14. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14(3):234-9. DOI:10.1093/eurjhf/hfr182
15. Spitaleri G, Lupón J, Domingo M, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep. 2021;11(1):732.
DOI:10.1038/s41598-020-79926-3
16. Buddeke J, Valstar GB, Dis I, et al. Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men. BMC Public Health. 2020;20(1):36. DOI:10.1186/s12889-019-7934-3
17. Available at: https://wonder.cdc.gov/controller/datarequest/D76. Accessed: 16.09.2021.
________________________________________________
2. Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure. 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circ Heart Fail. 2020;13(2):e006472. DOI:10.1161/CIRCHEARTFAILURE.119.006472:e006472
3. Maddox T, Januzzi JL, Allen LA, et al. 2021 Upd ate to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Se t Oversight Committee. J Am Coll Cardiol. 2021;77(6):772-810. DOI:10.1016/j.jacc.2020.11.022
4. [Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Jjournal of Cardiology. 2016;8:7-13 (in Russian).
DOI:10.15829/1560-4071-2016-8-7-13
5. Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Infez Med. 2020;28(4):500-6.
6. Buckley BJR, Harrison SL, Fazio-Eynullayeva E, et al. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021;51(11):e13679. DOI:10.1111/eci.13679
7. Lee CCE, Ali K, Connell D, еt al. COVID-19-Associated Cardiovascular Complications. Diseases. 2021;9(3):47. DOI:10.3390/diseases9030047
8. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. MedRxiv. 2021;2021.07.23.21260998 (Preprint). DOI:10.1101/2021.07.23.21260998
9. Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PloS One. 2021;16(7):e0254523. DOI:10.1371/journal.pone.0254523
10. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. DOI:10.1002/ejhf.1858
11. Gerber Y, Weston SA, Redfield MM, et al. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996-1004. DOI:10.1001/jamainternmed.2015.0924
12. Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14 (in Russian). DOI:10.18087/cardio.2021.4.n1628
13. Sutcliffe S, Phillips C, Watson D, Davidson C. Trends in heart failure mortality in England and Wales since 1950. Eur J Intern Med. 2007;18(8):576-80.
DOI:10.1016/j.ejim.2007.03.014
14. Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14(3):234-9. DOI:10.1093/eurjhf/hfr182
15. Spitaleri G, Lupón J, Domingo M, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep. 2021;11(1):732.
DOI:10.1038/s41598-020-79926-3
16. Buddeke J, Valstar GB, Dis I, et al. Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men. BMC Public Health. 2020;20(1):36. DOI:10.1186/s12889-019-7934-3
17. Available at: https://wonder.cdc.gov/controller/datarequest/D76. Accessed: 16.09.2021.
Авторы
С.А. Бойцов*1,2
1 ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия;
2 ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России, Москва, Россия
*prof.boytsov@gmail.com
1 National Medical Research Center of Cardiology, Moscow, Russia;
2 Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
*prof.boytsov@gmail.com
1 ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России, Москва, Россия;
2 ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России, Москва, Россия
*prof.boytsov@gmail.com
________________________________________________
1 National Medical Research Center of Cardiology, Moscow, Russia;
2 Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia
*prof.boytsov@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.